Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
These patients fear gaining a few pounds, even after having lost a significant amount of weight since starting the medication
The paraventricular nucleus integrates these signals and coordinates downstream responses including reduced food intake
Until recently, the most effective new obesity medications, including semaglutide (Wegovy) and tirzepatide (Zepbound), were available only as injectables
Product Detail Product Tags Brief Introduction: Retatrutide is a glucose-dependent insulin-dependent polypeptide (GIP), glucagon-like peptide 1 (GLP-1) and glucagon (GCG) triple receptor agonist, it has attracted widespread attention because it can significantly improve blood sugar control, lipid metabolism and weight loss in patients with type 2 diabetes
This helps limit side effects, but it may also mean progress feels slower or inconsistent for a while
Neither peptide is FDA-approved for anything
